As of 2024-12-12, the Intrinsic Value of Puma Biotechnology Inc (PBYI) is
7.88 USD. This PBYI valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 2.94 USD, the upside of Puma Biotechnology Inc is
168.10%.
The range of the Intrinsic Value is 6.39 - 10.36 USD
PBYI Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
6.39 - 10.36 |
7.88 |
168.1% |
| DCF (Growth 10y) |
7.15 - 11.37 |
8.75 |
197.5% |
| DCF (EBITDA 5y) |
9.95 - 12.62 |
11.10 |
277.5% |
| DCF (EBITDA 10y) |
9.69 - 13.25 |
11.22 |
281.5% |
| Fair Value |
11.84 - 11.84 |
11.84 |
302.58% |
| P/E |
9.18 - 21.09 |
12.86 |
337.4% |
| EV/EBITDA |
11.75 - 18.37 |
13.05 |
343.9% |
| EPV |
3.78 - 5.53 |
4.66 |
58.5% |
| DDM - Stable |
3.05 - 6.28 |
4.67 |
58.7% |
| DDM - Multi |
3.34 - 5.53 |
4.18 |
42.2% |
PBYI Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
144.32 |
| Beta |
0.06 |
| Outstanding shares (mil) |
49.09 |
| Enterprise Value (mil) |
155.14 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.32% |
| Cost of Debt |
8.90% |
| WACC |
9.09% |